Royal Canin
A French-origin global pet-food brand built around research-led nutrition for cats and dogs.
Last updated November 4, 2026
AI crawler reads
6requests
2companies- Amazon3
- Anthropic3
- Profile
- 4
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 3, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Royal Canin is a French-origin pet-food brand and a division of Mars, Incorporated. It develops and sells nutrition for cats and dogs, with products organized around factors such as species, breed, life stage, size, lifestyle, physiological condition, and diagnosed health needs. The brand is particularly associated with veterinary diets, breed-specific formulas, and the principle of improving animal health through nutrition. The company was founded in 1968 by French veterinary surgeon Jean Cathary. While running a veterinary practice in the Gard region, Cathary treated dogs suffering from recurring skin and coat problems. He believed that diet was an important part of the solution and developed a cereal-based food in his garage. After observing positive results, he closed his practice and concentrated on manufacturing and distribution under the Royal Canin name. The company imported an extruder from the United States, becoming France's first dry pet-food manufacturer and an early European user of extrusion technology. Its initial commercial focus was breeders and German Shepherd clubs, supported by television advertising and professional recommendations. Royal Canin expanded rapidly during the 1970s. It incorporated as Royal Canin S.A., opened a larger factory at Aimargues, began distributing across Europe, and established a Spanish subsidiary. In 1972, Cathary sold the business to the Guyomarc'h Group, an animal-feed company. Guyomarc'h funded further expansion, including a research center at Saint-Nolff and a second French factory at Cambrai. Royal Canin subsequently established subsidiaries across Europe and broadened its portfolio beyond dry dog food to include canned food, cat food, and other animal nutrition products. The Guyomarc'h Group was acquired by Paribas Affaires Industrielles in 1990. After a difficult financial period in the early 1990s, Royal Canin was separated from the wider group and pursued a strategy centered on dry food, health through nutrition, and expertise in dogs. It was floated on the Paris stock exchange in 1997, then used its strengthened financial position to acquire Crown Pet Foods in 1999 and James Wellbeloved in 2000. Mars, Incorporated acquired Royal Canin in 2002, after European competition requirements led to the disposal of certain assets. Royal Canin was delisted after the acquisition and became part of Mars Petcare's international network. Under Mars, the brand continued to expand its veterinary and specialist portfolio. In 2004, it acquired the US and Canadian veterinary-food brands IVD, Medi-Cal, and Techni-Cal from Del Monte Foods. Royal Canin also developed manufacturing and logistics capacity in Europe, North America, South America, China, Russia, South Korea, and other markets. Its research activities include nutritional studies, veterinary collaboration, breed-focused work, and non-invasive product evaluation involving selected dogs and cats. The brand has also published professional and educational material, including Veterinary Focus and reference works on animal nutrition and breeds. Royal Canin sells through several channels: veterinary clinics, specialist pet retailers, breeders, shelters, working-dog organizations, and other professional networks. Its main product architecture includes everyday foods for cats and dogs, breed- and size-specific nutrition, and veterinary diets for conditions including urinary, gastrointestinal, allergic, hypoallergenic, dental, and weight-management needs. Some veterinary products are distributed under professional or prescription-related restrictions depending on the market. The brand has sponsored animal shows, breeder and veterinary events, and professional forums internationally. Its public activities have also included the Royal Canin Foundation, created in 2020 to support projects examining the role of companion animals in human health. Royal Canin remains an active global brand within Mars Petcare, with Cécile Coutens serving as…
History
Royal Canin began in 1968 when veterinarian Jean Cathary developed a cereal-based food for dogs with skin and coat problems. He produced the initial formula in his garage and, after seeing beneficial results, registered the Royal Canin trademark and left veterinary practice to manufacture pet food. By importing an American extruder, the company became the first French producer of dry pet food and one of the earliest European businesses to apply extrusion at industrial scale. Its first customers were primarily breeders and German Shepherd organizations. The business was incorporated as Royal Canin S.A. in 1970. A larger plant opened at Aimargues, and distribution expanded beyond France. Cathary sold the company to the Guyomarc'h Group in 1972. The new owner supported investment in research and development, including a research center at Saint-Nolff opened in 1973 and a second factory at Cambrai in 1975. During the following decade, Royal Canin established subsidiaries in several European countries, built additional manufacturing capacity, and diversified into canned food, cat food, and other animal-nutrition products. Paribas Affaires Industrielles acquired the Guyomarc'h Group in 1990. Royal Canin recorded a loss in 1993, but the business was subsequently separated from the wider group and placed under new leadership. During the 1990s, management emphasized dry food, health through nutrition, and dog-handling expertise. Royal Canin went public on the Paris stock exchange in 1997. The listing helped finance acquisitions including Crown Pet Foods in 1999 and James Wellbeloved in 2000. Mars, Incorporated acquired Royal Canin in 2002. The transaction required the disposal of certain assets under European competition conditions, and Royal Canin was delisted after becoming part of Mars. In 2004, the company acquired IVD, Medi-Cal, and Techni-Cal from Del Monte Foods, extending its veterinary-food presence in North America. The Mars period brought further international manufacturing and logistics development. Facilities and investments were reported in France, Russia, Poland, Canada, the United States, China, Brazil, and South Korea. Research centers and pet-care facilities supported work on breed differences, growth, digestive capacity, bone development, dental health, allergies, urinary health, and other nutritional requirements. Royal Canin's product philosophy has been summarized as health through nutrition: formulas are intended to address defined needs rather than treat pets as small versions of humans. Royal Canin also developed a professional information ecosystem. It collaborated with veterinarians and academic experts on encyclopedias and nutrition publications and has published Veterinary Focus for the veterinary community. The company participates in breeder, veterinary, and animal-show events and distributes products through specialist, professional, and clinical channels. The brand faced reputational criticism in 2013 after an animal-welfare organization linked a Ukrainian subsidiary's sponsorship activity to events involving illegal bear-baiting and dog fighting. Royal Canin confirmed the allegations and committed to taking action. It was also among the brands affected by the wider 2007 pet-food recalls. In later years, Royal Canin continued product development, including expanded hypoallergenic nutrition and dental-care products. Mars announced substantial investment in French and North American facilities in 2021. Cécile Coutens became president in 2022, and Royal Canin marked its 50th anniversary in 2018.
- 2023
Dental-care and photography initiatives launch
[1]Royal Canin expands hypoallergenic nutrition, introduces Dental Care products, and launches its first international photography award.
- 2022
Cécile Coutens becomes president
[1]Cécile Coutens succeeds Loïc Moutault and becomes the first woman to lead the brand.
- 2021
Mars announces major facility investments
[1]Mars announces investment in Royal Canin's French headquarters and production infrastructure, as well as expansions in North American facilities.
- 2020
Royal Canin Foundation is created
[1]The foundation is established to support research and programs concerning the role of companion animals in human health.
- 2018
50th anniversary
[1]Royal Canin marks five decades since its founding.
- 2007
Pet-food recall period
[2]Royal Canin is among brands affected by the international 2007 pet-food recalls.
- 2004
North American veterinary brands are acquired
[1]Royal Canin acquires IVD, Medi-Cal, and Techni-Cal from Del Monte Foods.
- 2002
Mars acquires Royal Canin
[1]Mars, Incorporated purchases Royal Canin, which is subsequently delisted and integrated into Mars Petcare.
- 1997
Royal Canin is listed in Paris
[1]A portion of the company is floated on the Paris stock exchange to support expansion and acquisitions.
- 1990
Paribas acquires Guyomarc'h
[1]Paribas Affaires Industrielles purchases the Guyomarc'h Group, bringing Royal Canin under new ownership.
Products and positioning
Premium, science-led and professionally informed pet nutrition, emphasizing precise formulation for specific physiological, breed, life-stage, lifestyle, and health requirements.
Breed-specific dog and cat food
Royal Canin Breed Health Nutrition
A family of formulas tailored to characteristics associated with particular breeds. Product development considers factors such as body size, jaw shape, coat, digestive tendencies, and breed-linked nutritional requirements. The range is intended for everyday feeding rather than treatment of a diagnosed disease.
Life-stage and size-specific food
Royal Canin Size Health Nutrition
Nutrition organized around the size and life stage of dogs, including puppy, adult, and senior needs. Formulas address differences in energy requirements, growth, digestion, kibble design, and weight management across small, medium, and large dogs.
Cat food
Royal Canin Feline Health Nutrition
A broad cat-food portfolio covering life stage, lifestyle, body condition, breed, and selected sensitivities. The range includes dry and wet formats and is designed around feline-specific considerations such as digestive tolerance, urinary health, weight control, and the texture and shape of food.
Veterinary nutrition
Royal Canin Veterinary Diet
A clinically oriented range for cats and dogs with specific nutritional needs. Depending on market rules and product type, formulas may be supplied through veterinary channels or require professional recommendation. Areas include urinary, gastrointestinal, renal, allergy, hypoallergenic, dental, and weight-management support.
Dental-support pet food · 2023
Royal Canin Dental Care
Products introduced to support oral care through kibble design and texture. The pieces are intended to encourage chewing and provide a mechanical cleaning effect, complementing rather than replacing veterinary dental care.
Medication-administration treat
Pill Assist
A soft treat designed to help owners administer tablets or capsules to cats by enclosing or masking medication. It is a supportive product for medication routines rather than a therapeutic food.
Controversies
2017
Criticism of kibble quality
Royal Canin was criticized in a France 5 report and in a book about pet kibble quality. The criticism concerned the composition and perceived quality of commercial dry pet food; the cited material did not establish a regulatory finding against the brand.
2013
Ukrainian event sponsorship controversy
Four Paws alleged that Royal Canin's Ukrainian subsidiary sponsored events connected with illegal bear-baiting and dog fighting. Royal Canin confirmed the allegations and stated that it would take steps to stop sponsorship of such events and support bear protection.
Marketing campaigns
- 2023Royal Canin Photography Award
International
An international photography competition celebrating the individuality and diversity of cats and dogs and using visual arts to increase public awareness of companion animals.
Outcome. Created a recurring cultural and awareness platform for the brand.
- 1968Health Through Nutrition
France · International
Royal Canin's foundational positioning linked pet health with nutrition developed from veterinary observation and nutritional research.
Outcome. Became the brand's enduring strategic and communications principle.
- 1968Breeder and German Shepherd outreach
France · Europe
The early business targeted breeders and German Shepherd clubs, using professional networks and television advertising to establish credibility for its dry-food products.
Outcome. Helped establish Royal Canin in specialist and professional pet-care channels.
Brand decisions
2023
Expand hypoallergenic and dental nutritionProduct launchBackground
Royal Canin continued to broaden products addressing common veterinary and preventive-care needs.
Action taken
The brand expanded its hypoallergenic range and launched Dental Care products using specially designed kibble texture.
Aftermath
The move strengthened Royal Canin's positioning around targeted nutrition and everyday preventive support.
2021
Expand manufacturing and headquarters capacityStrategyBackground
Mars planned additional capacity and modernization for Royal Canin's manufacturing and research network.
Action taken
Mars announced investment in the Aimargues headquarters and French operations, as well as major expansion projects at North Sioux City and Lebanon in the United States.
Aftermath
The investments were intended to increase production capacity and reinforce Royal Canin's regional and global supply network.
Announced investment. €46 million in France; $185 million at North Sioux City; $200 million at Lebanon (2021)
2004
Acquire IVD, Medi-Cal, and Techni-CalM&ABackground
Royal Canin sought to strengthen its presence in veterinary nutrition, especially in the US and Canada.
Action taken
The company acquired three veterinary-food brands from Del Monte Foods.
Aftermath
The transaction broadened Royal Canin's North American clinical nutrition portfolio.
Acquisition price. $82.5 million (2004)
2002
Accept acquisition by MarsM&ABackground
Paribas Affaires Industrielles sold its holding in Royal Canin to Mars, combining the French-origin specialist with a global pet-care distribution group.
Action taken
Royal Canin joined Mars Petcare and was delisted from the Paris stock exchange after the transaction.
Aftermath
The deal gave Royal Canin access to Mars's international operating and distribution network while preserving Royal Canin as a distinct brand.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/royal-canin · Editorial policy · How profiles are compiled